Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up

Table 6

MRproADM performance in predicting ICU or overall mortality using a cut-off of 1.4 nmol/L.

	ICU mortality	Overall mortality
Sensitivity	86.1%	81.1%
Specificity	37.5%	39.8%
Positive predictive value	27.0%	48.5%
Negative predictive value	90.91%	75.0%
Positive likelihood ratio	1.38	1.35
Negative likelihood ratio	0.37	0.48